Key result
SPING block is linked to a ~4-point pain score reduction in frail hip fracture patients.
Why the study?
Effective pain management minimizing opioid use is critical in non-operative management of proximal femur fractures in frail older adults.
Does Spinal Phenol IN Glycerol (SPING) block reduce pain intensity and opioid consumption while enabling mobility in frail older adults with proximal femur fractures receiving non-operative management?
Cohort (n=68)
No
Does Spinal Phenol IN Glycerol (SPING) block reduce pain intensity and opioid consumption while enabling mobility in frail older adults with proximal femur fractures receiving non-operative management?
In frail older adults opting for palliative non-operative management of proximal femur fractures, a single-shot SPING block provides rapid, definitive pain relief, eliminates opioid requirements in most patients, and facilitates hospital discharge within a median of one day.
Answers are grounded in this paper and cite their sources.
May support SPING block for pain control in non-operative femur fractures; leaves open randomized confirmation of mobility and safety.
Background/Objectives: Spinal Phenol IN Glycerol (SPING) block is a novel palliative pain treatment for the non-operative management of proximal femur fractures (PFFs) in older adults living with frailty. Effective pain management that aligns with patient preferences and minimizes opioid use is critical in this setting. This study evaluated the patient, safety, and process outcomes of SPING block in this population. Methods: A retrospective cohort study was conducted in a suburban teaching hospital from March 2021 to June 2024, which included sixty-eight older adults living with frailty that suffered from a PFF and received SPING block. Data were collected from the Electronic Patient Records. The patient living situation was visualized with a Sankey diagram. Changes in pain scores and opioid use were assessed using the Wilcoxon Signed Rank test. Results: The median patient age was 89 years (Interquartile range (IQR) 83–92). Most were severely or terminally ill (American Society of Anesthesiologists (ASA) ≥ 4, 72%) and had cognitive impairment or dementia (68%). SPING block was effective in 93% of patients, significantly reducing median pain scores (4 [IQR 3–5] to 0 [IQR 0–1], p < 0.001) and opioid use (15 mg/day [IQR 4–30] to 0 mg/day [IQR 0–0], p < 0.001). Within 24 h, 84% could sit upright and 44% could transfer between their bed and chair. The median time to discharge was one day (IQR 0–3), with a median survival of 13 days (IQR 7–44). Conclusions: This study supports SPING block as a viable option for older adults living with frailty suffering from a PFF who opt for non-operative management in a palliative setting. SPING block for PFFs in a palliative setting offers effective pain relief, reduces opioid use, and enables mobility for older adults living with frailty. Follow-up is essential to monitor efficacy and safety. Prospective studies are needed to confirm these findings.
No takes yet. Share an insight, caveat, or question.
Velden et al. (2025) conducted a cohort in Proximal femur fractures (PFFs) in older adults living with frailty receiving non-operative management (n=68). Spinal Phenol IN Glycerol (SPING) block was evaluated on Pain intensity (Numeric Rating Scale [NRS] score before vs. immediately after SPING block) (p=< 0.001). SPING block reduced median pain scores from 4 to 0 and median opioid use from 15 to /day in frail older adults with proximal femur fractures.
Synapse has enriched 10 related papers. Consider them for comparative context: